New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Published Sep 14, 2020

New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Guidelines recommend PARP inhibitors for a wider group of women; this is based on recent studies that found these drugs improve survival rates.

NOW
PLAYING
Customizing Your Ovarian Cancer Treatment Plan
NOW
PLAYING
Making the Move to Maintenance Therapy
NOW
PLAYING
Most Recent PARP Inhibitor Approval for Ovarian Cancer
NOW
PLAYING
What the New Ovarian Cancer Drug Combo Approval Means for Patients
NOW
PLAYING
When Are PARP Inhibitors Used for Ovarian Cancer?
NOW
PLAYING
Ovarian Cancer Maintenance Therapy & Recurrence
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.